A non-viral gene delivery system designed for clinical use

Author： Fratantoni Jc   Dzekunov S   Singh V   Liu Ln  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.5, Iss.2, 2003-01, pp. : 208-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles

By Mishra Swaroop   Webster Paul   Davis Mark E.  

European Journal of Cell Biology, Vol. 83, Iss. 3, 2004-04 ,pp. : 97-111

Urban & Fischer

Access to resources Recommend Favorite

Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC

By van Leeuwen EBM   Cloosen S   Senden-Gijsbers BLMG   Germeraad WTV   Bos GMJ  

Cytotherapy, Vol. 8, Iss. 1, 2006-02 ,pp. : 36-46

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical gene-marking of mesenchymal cells

By Horwitz Em   Kasow Ka   Hofmann Tj  

Cytotherapy, Vol. 5, Iss. 3, 2003-01 ,pp. : 194-196

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Delivery and tracking of therapeutic cell preparations for clinical cardiovascular applications

By de Silva R   Lederman RJ  

Cytotherapy, Vol. 6, Iss. 6, 2004-12 ,pp. : 608-614

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Is retroviral gene marking too dangerous to use?

By Brenner Mk   Heslop He  

Cytotherapy, Vol. 5, Iss. 3, 2003-01 ,pp. : 190-193

Ashgate Publishing Ltd

Access to resources Recommend Favorite